Document Detail


Antilip®: treatment of subjects with high total cholesterol tolerability and efficacy in a short-term registry study.
MedLine Citation:
PMID:  20657529     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
AIM: The aim of the paper was to describe a new formula (Antilip®) consisting of very low dosages of polyglucosamine, phytosterols and Monascus purpureus. It was given to subjects affected by high cholesterol levels.
METHODS: The formula was used in combination with mild physical exercise (8 MET/h/week) and mild diet (reduction of cholesterol intake through foods containing <80 mg/100 g). The product combination was tested in an 8-week registry study, comparing those subjects to 33 subjects with no Antilip® treatment but following the same mild exercise training and diet.
RESULTS: Results showed that Antilip® was effective in significantly reducing the total cholesterol levels from 268+/-23.2 to 201+/-11.4, whereas in the control group the reduction was almost absent (from 273+/-27 to 267+/-28).
CONCLUSION: Data shows that Antilip® is a safe and effective treatment for hypercholesterolemia.
Authors:
M R Cesarone; A Ledda; G Belcaro; A Ricci; S Stuard; L Pellegrini; E Ippolito; U Cornelli
Related Documents :
8832529 - Bone density and cyclic ovarian function in trained runners and active controls.
8054959 - Effects of chromium picolinate supplementation on body composition, strength, and urina...
17623749 - Exercise reverses high-fat diet-induced impairments on compartmentalization and activat...
10659299 - Effect of diet on thoroughbred horses with recurrent exertional rhabdomyolysis performi...
11428689 - Nutritional practices of male and female endurance cyclists.
19665869 - Effects of cafeteria diet on the jejunum in sedentary and physically trained rats.
15730429 - Hypotensive and lipid regulatory actions of 4-hydroxyderricin, a chalcone from angelica...
11392099 - The effect of fluvastatin on fibrinolytic factors in patients with hypercholesterolemia.
19110249 - Anti-atherogenic effects of montelukast associated with reduced mcp-1 expression in a r...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Panminerva medica     Volume:  52     ISSN:  1827-1898     ISO Abbreviation:  Panminerva Med     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-07-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0421110     Medline TA:  Panminerva Med     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  15-9     Citation Subset:  IM    
Affiliation:
Irvine3 Labs, Department Biomedical Sciences, Chieti-Pescara University, Pescara, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Faster healing of venous ulcers with crystacide: a clinical and microcirculatory 8-week registry stu...
Next Document:  Investigation of Pycnogenol® in combination with coenzymeQ10 in heart failure patients (NYHA II/III...